LSPedia Insights on FDA DSCSA Compliance Exemptions: Key Deadlines Beyond Stabilization

Matt Vincent, Director of Sales at LSPedia, breaks down the FDA’s DSCSA exemptions and their importance as the stabilization period ends on November 27, 2024. Learn how these exemptions provide continued flexibility for trading partners facing data exchange challenges and what this means for your compliance journey beyond the stabilization period. Matt outlines key deadlines and shares how LSPedia can support your compliance strategy, ensuring patient safety and uninterrupted supply chain operations. For further questions, reach out to Matt (mtvincent@lspedia.com) or the LSPedia team (dscsa@lspedia.com)!